Posts Feed
Comments Feed

Archive for the 'Hypertension' Category

Rasilez HCT(R) Receives Recommendation For European Approval As A Single-pill Combination To Treat High Blood Pressure

Nov 25th 2008Drug InformationHypertension

Rasilez HCT® (aliskiren and hydrochlorothiazide) received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorization as a new treatment for high blood pressure. Rasilez HCT is a single-pill combination of two high blood pressure medicines - first-in-class direct renin inhibitor Rasilez®[1] (aliskiren) and the diuretic hydrochlorothiazide (HCT).

More: continued here

No Comments »

Lack Of Sleep And Rising Nighttime Blood Pressure Linked To Cardiovascular Disease

Nov 21st 2008Drug InformationHypertension

A report published in the November 10 issue of Archives of Internal Medicine finds that people who sleep less than 7.5 hours per day may have a higher future risk of heart disease. Kazuo Eguchi, M.D., Ph.D. (Jichi Medical University, Tochigi, Japan) and colleagues also find an increased risk of heart disease among people who have little sleep combined with overnight elevated blood pressure.

More: continued here

No Comments »

FREEDOM-C Trial Of Oral Treprostinil In Pulmonary Arterial Hypertension Fails To Meet Primary Endpoint

Nov 21st 2008Drug InformationHypertension

United Therapeutics Corporation (Nasdaq: UTHR) announced the results of the FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary arterial hypertension (PAH). Preliminary analysis demonstrates that the trial did not achieve statistical significance for the primary endpoint, six minute walk (6MW) distance at Week 16.

More: continued here

No Comments »

« Prev - Next »

1